Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Return on Assets (2016 - 2025)

Northwest Biotherapeutics (NWBO) has 15 years of Return on Assets data on record, last reported at 2.44% in Q3 2025.

  • For Q3 2025, Return on Assets fell 2.0% year-over-year to 2.44%; the TTM value through Sep 2025 reached 2.44%, down 2.0%, while the annual FY2024 figure was 2.72%, 67.0% down from the prior year.
  • Return on Assets reached 2.44% in Q3 2025 per NWBO's latest filing, up from 2.57% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.77% in Q1 2022 and bottomed at 2.8% in Q1 2025.
  • Average Return on Assets over 5 years is 2.04%, with a median of 2.13% recorded in 2023.
  • Peak YoY movement for Return on Assets: soared 168bps in 2021, then tumbled -150bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 1.0% in 2021, then crashed by -134bps to 2.35% in 2022, then grew by 13bps to 2.05% in 2023, then decreased by -29bps to 2.65% in 2024, then grew by 8bps to 2.44% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 2.44% in Q3 2025, 2.57% in Q2 2025, and 2.8% in Q1 2025.